KMT HEPATECH INC has a total of 15 patent applications. Its first patent ever was published in 2000. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and agriculture are DELTAGEN INC, IMMUNOKICK INC and KOIKE CHIHIRO.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Australia | 3 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Israel | 1 | |
#6 | Japan | 1 | |
#7 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Agriculture | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Animal care | |
#5 | Medical preparations | |
#6 | Enzymes | |
#7 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Kneteman Norman M | 13 |
#2 | Tyrrell D Lorne | 9 |
#3 | Mercer David F | 7 |
#4 | Tyrrell David Lorne | 3 |
#5 | Azad Abdu F | 3 |
#6 | Richardson Christopher | 3 |
#7 | Hsu Eric C | 3 |
#8 | Elliott John F | 3 |
#9 | Sacci John B Jr | 3 |
#10 | Tyrrell Lorne D | 2 |
Publication | Filing date | Title |
---|---|---|
EP1784640A2 | Malarial animal model having a chimeric human liver | |
AU2003260223A8 | Therapeutic system targeting pathogen proteases and uses thereof | |
US6509514B1 | Chimeric animal model susceptible to human hepatitis C virus infection |